InterMune

InterMune to Present at Canaccord Adams Conference (PR Newswire)

yahoo.com     2 hrs ago          

Thursday August 7, 4:00 pm ET BRISBANE, Calif., Aug. 7 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN - News ) today announced that Daniel G. Welch, Chairman, CEO and President of InterMune, will present at the...                    

comments

Vertex falls on data for Schering hepatitis drug

ibtimes.com     Aug 4, 2008   9 related          

NEW YORK - Shares of Vertex Pharmaceuticals Inc. fell Monday after Schering-Plough Corp. reported positive data from a trial of a hepatitis C drug, showing it could be a strong competitor to Vertex's candidate telaprevir. In...                    

comments

                   

InterMune Reports Second Quarter 2008 Financial Results and Business Highlights

prnewswire.com     Jul 31, 2008   5 related          

InterMune Reports Second Quarter 2008 Financial Results and Business Highlights - InterMune, Inc. (Nasdaq: ITMN) today announced results from operations for the second quarter and six months ended June 30, 2008. At the AASLD...                    

comments

Media Advisory - BMO Capital Markets to Host 8th Annual Focus On Healthcare Conference (PR Newswire)

yahoo.com     Jul 30, 2008   2 related          

BMO Capital Markets, the investment and corporate banking arm of BMO Financial Group , will hold its eighth annual two-day conference, Focus On Healthcare, Tuesday, August 5 and Wednesday, August 6, at the Millennium Broadway...                    

comments

Array BioPharma Inc. Earnings Call scheduled for Tue, Aug 12 (CCBN)

yahoo.com     Jul 29, 2008          

Array BioPharma Inc. Earnings Conference Call (Q4 2008) Scheduled to start Tue, Aug 12, 2008, 9:00 am Eastern After the event has finished, the audio will be available from this page until Thu, Aug 13, 2009 Array BioPharma,...                    

comments

InterMune to Release Second Quarter 2008 Financial Results and Provide Business Update on July 31...

yahoo.com     Jul 24, 2008   2 related          

Thursday July 24, 4:01 pm ET BRISBANE, Calif., July 24 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN - News ) announced today that it will release second quarter 2008 financial results and provide a business update on...                    

comments

                   

Federal Judge Refuses to Accept Guilty Plea in Health Care Fraud Case

law.com     Jul 19, 2008          

Chi Yang faced prison time and hundreds of thousands of dollars in fines and restitution when he agreed to plead guilty in connection with fraudulent sales made by his biotech company. Then federal Judge Saundra Armstrong, in...                    

comments

                   

Wall street signals point to a good year for Pharma and Biotech

biotechnology-stock.blogspot.com     Jun 30, 2008   2 related          

It is hard to find any signs of optimism on wall street these days. The Nasdaq Biotech Index is flat for the year, outpacing the Nasdaq, and may signal a good year for Pharmaceutical and Biotech names. Interestingly, the...                    

comments

                   

Infectious Disease Companies Discussed in Wall Street Transcript Biotechnology Report (Wall...

yahoo.com     Jun 27, 2008   3 related          

67 WALL STREET, New York - The Wall Street Transcript has just published its Biotechnology issue, a report offering a timely review of the sector to serious investors and industry executives. The full issue is available by...                    

comments

InterMune to Present at Jefferies Healthcare Conference (PR Newswire)

yahoo.com     Jun 20, 2008   2 related          

BRISBANE, Calif., June 20 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN - News ) today announced that John Hodgman, Senior Vice President and Chief Financial Officer of InterMune, will present at the Jefferies 2nd...                    

comments

1 2 3 4 5 next »